A New Oral Option for Management of Endometriosis-Associated Pain

FDA approval of gonadotropin-releasing hormone (GnRH) antagonist elagolix as an oral agent for management of moderate-to-severe pain associated with endometriosis provides an important treatment option for a condition that compromises quality of life for approximately 10% of women of reproductive age. Types of pain associated with endometriosis include painful periods, painful ovulation, pain during or [...]

A New Oral Option for Management of Endometriosis-Associated Pain2020-10-06T02:16:59-05:00

Health Decisions Embraces #NextGenContraception Campaign

Health Decisions' CEO Patrick Phillips Supports the #NextGenContraception Campaign Health Decisions is a women's health specialty CRO with extraordinary experience and capabilities in contraceptive research. For more than 20 years, Health Decisions has served as the Coordinating Center for the Contraceptive Clinical Trials Network of the National Institute of Child Health and Human [...]

Health Decisions Embraces #NextGenContraception Campaign2020-10-06T02:19:36-05:00
Go to Top